½ÃÀ庸°í¼­
»óǰÄÚµå
1621803

¼¼°èÀÇ »óó ºÀÇÕ ¹× ÷´Ü »óó Ä¡·á ½ÃÀå : Á¦Ç°, ¿ëµµ ¹× ÃÖÁ¾ »ç¿ëÀÚº° - ¿¹Ãø(2025-2030³â)

Wound Closure & Advanced Wound Care Market by Product (Collagen-Based Sealants, Fibrin-Based Sealants, Hydrocolloids-Based Sealants), Application (Acute Wounds, Chronic Wounds), End-User - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 189 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

»óó ºÀÇÕ ¹× ÷´Ü »óó Ä¡·á ½ÃÀåÀº 2023³â¿¡ 163¾ï 4,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú½À´Ï´Ù. 2024³â¿¡´Â 178¾ï 6,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç CAGR 9.47%·Î ¼ºÀåÇØ 2030³â¿¡´Â 307¾ï 8,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

»óó ºÀÇÕ ¹× ÷´Ü »óó Ä¡·á ½ÃÀå¿¡´Â ºÀÇÕ»ç, ½ºÅ×ÀÌÇÃ, ½Ç¶õÆ®, Á¶Á÷ Á¢ÂøÁ¦, ÇÏÀ̵å·ÎÄÝ·ÎÀ̵å, ¾Ë±ä»ê ¿°, Æû µå·¹½Ì°ú °°Àº °í±Þ Ä¡À¯ Ä¡·á¸¦ Æ÷ÇÔÇÑ Á¾ÇÕÀûÀÎ Á¦Ç°±ºÀÌ Æ÷ÇԵ˴ϴÙ. ÀÌ·¯ÇÑ ¼Ö·ç¼ÇÀº ´Ù¾çÇÑ ¼Õ»ó ¹× ¼ö¼ú ÈÄ »óó¸¦ °ü¸®Çϰí Ä¡À¯ ½Ã°£À» ´ÜÃàÇÏ¸ç °¨¿°À» ¿¹¹æÇÏ´Â µ¥ ÇʼöÀûÀÔ´Ï´Ù. ¼¼°è Àα¸ÀÇ °í·ÉÈ­¿Í ¸¸¼º »óó ¹× ¼ö¼ú Áõ°¡·Î ÷´Ü »óó °ü¸® Á¦Ç°¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖÀ¸¸ç, ƯÈ÷ º´¿ø, Áø·á¼Ò ¹× ÀçÅÃÄ¡·á ÇöÀå¿¡¼­ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ½ÃÀå ¼ºÀåÀº »ý¸í°øÇÐÀÇ ¹ßÀü, ´ç´¢º´°ú ºñ¸¸ Áõ°¡, ÷´Ü Ä¡·á ¿É¼Ç¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó Å©°Ô ¿µÇâÀ» ¹Þ°í ÀÖ½À´Ï´Ù. ³ª³ë±â¼ú°ú »ýüÀç·áÀÇ À¶ÇÕÀº Á¦Ç°ÀÇ È¿°ú¿Í ȯÀÚ Ä¡·á °á°ú¸¦ °³¼±Çϰí Çõ½ÅÀÇ Å« ±âȸ¸¦ °¡Á®´Ù ÁÙ ¼ö ÀÖ½À´Ï´Ù. µû¶ó¼­ Ç×±ÕÁ¦¸¦ ÇÔÀ¯ÇÑ Èí¼ö¼º ºÀÇÕ»ç ¹× ÇÏÀ̵å·ÎÆÄÀ̹ö µå·¹½ÌÀÇ ¿¬±¸°³¹ß¿¡ ´ëÇÑ ÅõÀÚ´Â °æÀï ¿ìÀ§¸¦ °¡Á®´Ù ÁÙ ¼ö ÀÖ½À´Ï´Ù. ±×·¯³ª ÀÌ ½ÃÀåÀº ³ôÀº Á¦Ç° ºñ¿ë, ±î´Ù·Î¿î ±ÔÁ¦ ¿ä°Ç, ÀüÅëÀûÀÎ Ä¡·á¹ý°úÀÇ °æÀï µî ¿©·¯ °¡Áö °úÁ¦¸¦ ¾È°í ÀÖ½À´Ï´Ù. ¹Ì°³¹ß Áö¿ª¿¡¼­´Â ÀÎÁöµµ¿Í Á¢±Ù¼ºÀÌ Á¦ÇÑÀûÀ̾ ½ÃÀå È®´ë¿¡ °É¸²µ¹ÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. ÇöÀç ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇϱâ À§Çؼ­´Â Àü·«Àû ÆÄÆ®³Ê½ÊÀ» ÅëÇØ ½ÅÈï °æÁ¦±Ç¿¡ ÁøÃâÇϰí, ¼ÒºñÀÚ ±³À°À» °­È­Çϰí, ¿ø°Ý ÀÇ·á ¹× AI¿Í °°Àº »óó °ü¸®¸¦ À§ÇÑ µðÁöÅÐ Çコ Áøº¸¸¦ Ȱ¿ëÇÏ´Â °ÍÀÌ ÁÁ½À´Ï´Ù. ½ÃÀåÀÇ Æ¯¼ºÀº ¿ªµ¿ÀûÀ̸ç, °³ÀÎÈ­µÈ ȯÀÚ Áß½É Ä¡·á·Î ÇâÇÏ´Â °æÇâÀÌ °­ÇÕ´Ï´Ù. Áö¼ÓÀûÀÎ Çõ½ÅÀÌ Áß¿äÇϸç, ºñ¿ë È¿À²ÀûÀÌ°í ´ÙÀç´Ù´ÉÇϸç Áö¼Ó °¡´ÉÇÑ ¼Ö·ç¼Ç °³¹ß¿¡ ÁýÁßÇØ¾ß ÇÕ´Ï´Ù. Áö¼Ó°¡´É¼ºÀ» ¿ì¼±½ÃÇϰí, °í±Þ ºÐ¼®À» ÅëÇÕÇϰí, °ø±Þ¸ÁÀ» ÃÖÀûÈ­ÇÏ´Â Á¶Á÷Àº °æÀï·ÂÀ» È®º¸ÇÒ °¡´É¼ºÀÌ ³ô½À´Ï´Ù. µû¶ó¼­ ¼¼°è ÀÇ·á Æ®·»µå¸¦ ÆÄ¾ÇÇϰí, ½ÅÈï ½ÃÀå¿¡ ÅõÀÚÇϰí, ´ÙÇÐÁ¦Àû ¿¬±¸¸¦ ÅëÇØ Çõ½ÅÀ» ÃËÁøÇÏ´Â °ÍÀº Áö¼Ó °¡´ÉÇÑ ¼ºÀåÀ» À§ÇÑ ÇʼöÀûÀÎ ´Ü°èÀÔ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁØ ¿¬µµ(2023³â) 163¾ï 4,000¸¸ ´Þ·¯
ÃßÁ¤ ¿¬µµ(2024³â) 178¾ï 6,000¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ(2030³â) 307¾ï 8,000¸¸ ´Þ·¯
CAGR(%) 9.47%

½ÃÀå ¿ªÇÐ: ºü¸£°Ô ÁøÈ­ÇÏ´Â »óó ºÀÇÕ ¹× ÷´Ü »óó Ä¡·á ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

»óó ºÀÇÕ ¹× ÷´Ü »óó Ä¡·á ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ º¯È­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÅõÀÚ °áÁ¤À» ³»¸®°í, Àü·«ÀûÀÎ ÀÇ»ç°áÁ¤À» Á¤±³È­Çϸç, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Æ®·»µå¸¦ Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª Àü¹Ý¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ ÁÙÀÏ ¼ö ÀÖÀ¸¸ç, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¹× ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • °í·É Àα¸ Áõ°¡, ¸¸¼º »óó ȯÀÚ Áõ°¡
    • °¢±¹ÀÇ ÀÇ·á ÀÎÇÁ¶ó ¹× Á¢±Ù¼º Çâ»ó
    • Àü ¼¼°è »ç°í ¹× ¿Ü»ó·ü »ó½Â
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • »óó Ä¡·á ¹× °ü¸®¿¡ µû¸¥ ³ôÀº ºñ¿ë
  • ½ÃÀå ±âȸ
    • ½º¸¶Æ® »óó °ü¸® Á¦Ç° ¹× ±â¼ú ¼Ò°³
    • ½ÅÈï °æÁ¦±¹ÀÇ È­»ó Ä¡·á ¼¾ÅÍ °³¹ß
  • ½ÃÀå °úÁ¦
    • ¸¸¼ºÃ¢»ó Ä¡·á¿¡ µû¸¥ º¹À⼺ ¹®Á¦

Porter's Five Forces »óó ºÀÇÕ ¹× ÷´Ü »óó Ä¡·á ½ÃÀåÀ» Ž»öÇÏ´Â Àü·«Àû µµ±¸

Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. PorterÀÇ Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ Ž»öÇÒ ¼ö ÀÖ´Â ¸íÈ®ÇÑ ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÅëÂû·ÂÀ» ÅëÇØ ±â¾÷Àº °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ µµÀüÀ» ÇÇÇϰí, º¸´Ù °­·ÂÇÑ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : »óó ºÀÇÕ ¹× ÷´Ü »óó Ä¡·á ½ÃÀåÀÇ ¿ÜºÎ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº »óó ºÀÇÕ ¹× ÷´Ü »óó Ä¡·á ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀο¡ ´ëÇÑ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇϸç, PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀû À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¼±Á¦ÀûÀÌ°í ´Éµ¿ÀûÀÎ ÀÇ»ç°áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® »óó ºÀÇÕ ¹× ÷´Ü »óó Ä¡·á ½ÃÀå °æÀï ±¸µµ ÆÄ¾Ç

»óó ºÀÇÕ ¹× ÷´Ü »óó Ä¡·á ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü°ú °°Àº ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀïÀû À§Ä¡¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀåÀÇ ÁýÁßÈ­, ´ÜÆíÈ­ ¹× ÅëÇÕ Ãß¼¼¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖÀ¸¸ç, °ø±Þ¾÷ü´Â Ä¡¿­ÇÑ °æÀï ¼Ó¿¡¼­ ÀÚ½ÅÀÇ ÀÔÁö¸¦ °­È­ÇÒ ¼ö ÀÖ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÅëÂû·ÂÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º »óó ºÀÇÕ ¹× ÷´Ü »óó Ä¡·á ½ÃÀå¿¡¼­ÀÇ º¥´õ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â »óó ºÀÇÕ ¹× ÷´Ü »óó Ä¡·á ½ÃÀå¿¡¼­ °ø±Þ¾÷ü¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº º¥´õÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±â¹ÝÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖÀ¸¸ç, 4°³ÀÇ »çºÐ¸éÀ¸·Î º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·«Àû ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù. Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù.

»óó ºÀÇÕ ¹× ÷´Ü »óó Ä¡·á ½ÃÀå¿¡¼­ ¼º°øÇϱâ À§ÇÑ Àü·« ºÐ¼® ¹× ±ÇÀå »çÇ×

»óó ºÀÇÕ ¹× ÷´Ü »óó Ä¡·á ½ÃÀåÀÇ Àü·«Àû ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ÀÇ ÀÔÁö¸¦ °­È­ÇϰíÀÚ ÇÏ´Â ±â¾÷¿¡°Ô ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ½Äº°ÇÏ°í °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀº °æÀï ȯ°æÀÇ µµÀüÀ» ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ ü°è¸¦ ±¸ÃàÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÝ´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõµµ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù°¢È­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä ¹ßÀü, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú ¹ßÀü µîÀ» °ËÅäÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÷´Ü ±â¼ú, ¿¬±¸ °³¹ß Ȱµ¿ ¹× Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

ÀÌÇØ°ü°èÀÚµéÀÌ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï ´ÙÀ½°ú °°Àº Áß¿äÇÑ Áú¹®¿¡ ´ëÇÑ ´äº¯µµ Á¦°øÇÕ´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå Àü¸ÁÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹®, Áö¿ªÀº?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5.º¥´õ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå »óó ºÀÇÕ ¹× ÷´Ü »óó Ä¡·á ½ÃÀå : Á¦Ç°º°

  • Äݶó°Õ ±â¹Ý ½Ç¶õÆ®
  • ÇǺ기 ±â¹Ý ½Ç¶õÆ®
  • ÇÏÀ̵å·ÎÄÝ·ÎÀÌµå ±â¹Ý ½Ç¶õÆ®
  • ÇÕ¼º Á¢ÂøÁ¦

Á¦7Àå »óó ºÀÇÕ ¹× ÷´Ü »óó Ä¡·á ½ÃÀå : ¿ëµµº°

  • ±Þ¼º â»ó
    • È­»ó
    • ¿Ü°úÀû â»ó ¹× ¿Ü»ó
  • ¸¸¼º â»ó
    • ´ç´¢º´¼º Á·±Ë¾ç
    • ¿åâ
    • Á¤¸Æ¼º ÇÏÁö ±Ë¾ç

Á¦8Àå »óó ºÀÇÕ ¹× ÷´Ü »óó Ä¡·á ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • Ŭ¸®´Ð
  • ÀçÅà ÇコÄɾî
  • º´¿ø

Á¦9Àå ¾Æ¸Þ¸®Ä«ÀÇ »óó ºÀÇÕ ¹× ÷´Ü »óó Ä¡·á ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦10Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ »óó ºÀÇÕ ¹× ÷´Ü »óó Ä¡·á ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦11Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ »óó ºÀÇÕ ¹× ÷´Ü »óó Ä¡·á ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦12Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®, 2023³â
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023³â
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸®½ºÆ®

  • 3M Company
  • Argentum Medical
  • Axio Biosolutions Private Limited by Advamedica Inc.
  • B. Braun SE
  • Cardinal Health, Inc.
  • Coloplast A/S
  • Convatec Limited
  • Essity AB
  • Hollister Incorporated
  • Integra LifeSciences Corporation
  • Johnson & Johnson Services, Inc.
  • Lohmann & Rauscher GmbH & Co. KG
  • Medline Industries, LP
  • Medtronic PLC
  • MIMEDX Group, Inc.
  • Misonix, Inc. by Bioventus LLC
  • Molnlycke Health Care AB
  • Organogenesis Inc.
  • Paul Hartmann AG
  • PolarityTE, Inc.
  • Smith & Nephew PLC
  • Tides Medical
  • Tissue Regenix Ltd.
  • Urgo Ltd.
  • Zimmer Biomet Holdings, Inc.
LSH 25.01.03

The Wound Closure & Advanced Wound Care Market was valued at USD 16.34 billion in 2023, expected to reach USD 17.86 billion in 2024, and is projected to grow at a CAGR of 9.47%, to USD 30.78 billion by 2030.

The Wound Closure & Advanced Wound Care market encompasses a comprehensive range of products including sutures, staples, sealants, tissue adhesives, and advanced healing treatments like hydrocolloids, alginates, and foam dressings. These solutions are critical for managing a variety of injuries and post-surgical wounds, reducing healing time, and preventing infections. As global populations age and incidences of chronic wounds and surgeries increase, the necessity for advanced wound care products grows, with particular demand from hospitals, clinics, and home health settings. Market growth is heavily influenced by advancements in biotechnology, a heightened prevalence of diabetes and obesity, and increased awareness of advanced treatment options. The integration of nanotechnology and biomaterials presents significant opportunities for innovation by enhancing product efficacy and patient outcomes. Therefore, investing in R&D for absorbable sutures and hydrofiber dressings containing antimicrobial agents may offer competitive advantages. Nevertheless, the market is challenged by high product costs, stringent regulatory requirements, and substantial competition from traditional healing methods. Limited awareness and access in underdeveloped regions can further impede market expansion. To capitalize on current opportunities, expanding into emerging economies through strategic partnerships, increasing consumer education, and leveraging digital health advances for wound care management, such as telehealth and AI, are recommended. The market's nature is dynamic, with a robust inclination towards personalized and patient-centered care. Continuous innovation is crucial and should focus on developing cost-effective, versatile, and sustainable solutions. Organizations that prioritize sustainability, integrate advanced analytics, and optimize supply chains will likely gain a competitive edge. Consequently, staying abreast of global health trends, investing in emerging markets, and fostering innovation through cross-disciplinary research are vital steps for sustained growth.

KEY MARKET STATISTICS
Base Year [2023] USD 16.34 billion
Estimated Year [2024] USD 17.86 billion
Forecast Year [2030] USD 30.78 billion
CAGR (%) 9.47%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Wound Closure & Advanced Wound Care Market

The Wound Closure & Advanced Wound Care Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing geriatric population an increasing number of patients with chronic wounds
    • Improving healthcare infrastructure and access across economies
    • Globally rising rate of accidents and trauma cases
  • Market Restraints
    • High cost associated with wound care and management
  • Market Opportunities
    • Introduction of smart wound care products and technologies
    • Development of burn care centers in economies
  • Market Challenges
    • Complexity issues associated with chronic wound treatments

Porter's Five Forces: A Strategic Tool for Navigating the Wound Closure & Advanced Wound Care Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Wound Closure & Advanced Wound Care Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Wound Closure & Advanced Wound Care Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Wound Closure & Advanced Wound Care Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Wound Closure & Advanced Wound Care Market

A detailed market share analysis in the Wound Closure & Advanced Wound Care Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Wound Closure & Advanced Wound Care Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Wound Closure & Advanced Wound Care Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Wound Closure & Advanced Wound Care Market

A strategic analysis of the Wound Closure & Advanced Wound Care Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Wound Closure & Advanced Wound Care Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Argentum Medical, Axio Biosolutions Private Limited by Advamedica Inc., B. Braun SE, Cardinal Health, Inc., Coloplast A/S, Convatec Limited, Essity AB, Hollister Incorporated, Integra LifeSciences Corporation, Johnson & Johnson Services, Inc., Lohmann & Rauscher GmbH & Co. KG, Medline Industries, LP, Medtronic PLC, MIMEDX Group, Inc., Misonix, Inc. by Bioventus LLC, Molnlycke Health Care AB, Organogenesis Inc., Paul Hartmann AG, PolarityTE, Inc., Smith & Nephew PLC, Tides Medical, Tissue Regenix Ltd., Urgo Ltd., and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Wound Closure & Advanced Wound Care Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Collagen-Based Sealants, Fibrin-Based Sealants, Hydrocolloids-Based Sealants, and Synthetic Adhesives.
  • Based on Application, market is studied across Acute Wounds and Chronic Wounds. The Acute Wounds is further studied across Burns and Surgical & Traumatic Wounds. The Chronic Wounds is further studied across Diabetic Foot Ulcer, Pressure Ulcer, and Venous Leg Ulcer.
  • Based on End-User, market is studied across Clinics, Home Healthcare, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing geriatric population an increasing number of patients with chronic wounds
      • 5.1.1.2. Improving healthcare infrastructure and access across economies
      • 5.1.1.3. Globally rising rate of accidents and trauma cases
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with wound care and management
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of smart wound care products and technologies
      • 5.1.3.2. Development of burn care centers in economies
    • 5.1.4. Challenges
      • 5.1.4.1. Complexity issues associated with chronic wound treatments
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Proliferation of collagen-based sealants to support tissue healing
    • 5.2.2. Application: Preferences for wound closure & advanced wound care in chronic wounds such as diabetic foot ulcers
    • 5.2.3. End-User: Increased adoption in hospital setting owing to procedures ranging from surgery to emergency care
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Wound Closure & Advanced Wound Care Market, by Product

  • 6.1. Introduction
  • 6.2. Collagen-Based Sealants
  • 6.3. Fibrin-Based Sealants
  • 6.4. Hydrocolloids-Based Sealants
  • 6.5. Synthetic Adhesives

7. Wound Closure & Advanced Wound Care Market, by Application

  • 7.1. Introduction
  • 7.2. Acute Wounds
    • 7.2.1. Burns
    • 7.2.2. Surgical & Traumatic Wounds
  • 7.3. Chronic Wounds
    • 7.3.1. Diabetic Foot Ulcer
    • 7.3.2. Pressure Ulcer
    • 7.3.3. Venous Leg Ulcer

8. Wound Closure & Advanced Wound Care Market, by End-User

  • 8.1. Introduction
  • 8.2. Clinics
  • 8.3. Home Healthcare
  • 8.4. Hospitals

9. Americas Wound Closure & Advanced Wound Care Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Wound Closure & Advanced Wound Care Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Wound Closure & Advanced Wound Care Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Innosphere Ventures Fund Announces Major Investment in GelSana to Revolutionize Advanced Wound Care
    • 12.3.2. DuPont Launches New Soft Skin Adhesive for Wound Care Dressings
    • 12.3.3. Coloplast Expands Wound Care Offerings with Kerecis Acquisition
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3M Company
  • 2. Argentum Medical
  • 3. Axio Biosolutions Private Limited by Advamedica Inc.
  • 4. B. Braun SE
  • 5. Cardinal Health, Inc.
  • 6. Coloplast A/S
  • 7. Convatec Limited
  • 8. Essity AB
  • 9. Hollister Incorporated
  • 10. Integra LifeSciences Corporation
  • 11. Johnson & Johnson Services, Inc.
  • 12. Lohmann & Rauscher GmbH & Co. KG
  • 13. Medline Industries, LP
  • 14. Medtronic PLC
  • 15. MIMEDX Group, Inc.
  • 16. Misonix, Inc. by Bioventus LLC
  • 17. Molnlycke Health Care AB
  • 18. Organogenesis Inc.
  • 19. Paul Hartmann AG
  • 20. PolarityTE, Inc.
  • 21. Smith & Nephew PLC
  • 22. Tides Medical
  • 23. Tissue Regenix Ltd.
  • 24. Urgo Ltd.
  • 25. Zimmer Biomet Holdings, Inc.
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦